Regions
MAIN/REGIONS
regions/
Regions
  1. Americas
  2. Asia & Oceania
  3. Europe
  4. Middle East & Africa
  1. Solutions
  2. Products
  3. Insights
  4. About
  5. Careers
  6. Contact Us
MAIN/search
MAIN/Solutions
Solutions/
SOLUTIONS
  • Research & Development
  • Real World Evidence
  • Commercialization
  • Safety & Regulatory Compliance
  • Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
THERAPEUTIC AREAS

Impacting People's Lives

"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.

LEARN MORE
Harness the power to transform clinical development

Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.

Research & Development Overview
Research & Development Quick Links
Real World Evidence. Real Confidence. Real Results.

Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.

REAL WORLD EVIDENCE OVERVIEW
Real World Evidence Quick Links
See markets more clearly. Opportunities more often.

Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.

COMMERCIALIZATION OVERVIEW
Commercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.

Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.

COMPLIANCE OVERVIEW
Safety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.

When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.

TECHNOLOGIES OVERVIEW
Technology Quick Links
MAIN/Products
Products/
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
REAL WORLD PRODUCTS

CASE STUDY

"Data in a Day

LEARN MORE
MAIN/Insights
Insights/
BLOGS, WHITE PAPERS & CASE STUDIES

Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.

DISCOVER INSIGHTS
THE IQVIA INSTITUTE

An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.

SEE LATEST REPORTS

INSTITUTE REPORT

"Digital Health Trends 2024 - Implications for Research and Patient Care

READ MORE

EMEA Insights

"IQVIA thought leadership with a focus on EMEA.

Learn more

WHITE PAPER

"DCTs Deliver Big ROI

LEARN MORE

WHITE PAPER

"Capturing value at scale: The $4 billion RWE imperative

LEARN MORE
MAIN/About
About/
FEATURED INNOVATIONS
  • IQVIA Connected Intelligence™
  • IQVIA Healthcare-grade AI™
  • IQVIA AI Assistant
  • Human Data Science Cloud
  • IQVIA Innovation Hub
  • Decentralized Trials
  • Patient Experience Solutions with Apple devices
WHO WE ARE
NEWS & RESOURCES

INVESTOR RELATIONS

"Visit our investor relations site for more information.

LEARN MORE
Unlock your potential to drive healthcare forward

By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.

LEARN MORE
IQVIA AI is Healthcare-grade AI

Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.

LEARN MORE
Meet the IQVIA AI Assistant

Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.

LEARN MORE
Your healthcare data deserves more than just a cloud.

The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.

LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships

The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.

LEARN MORE
Proven, faster DCT solutions

IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.

LEARN MORE
IQVIA Patient Experience Solutions with Apple devices

Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.

LEARN MORE
MAIN/Careers
Careers/
IQVIA Careers
Featured Careers
Stay Connected

WE'RE HIRING

"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.

VIEW ROLES
MAIN/Contact Us
Contact Us/
White Paper
​Engage with Confidence: Managing Online Adverse Event Reporting
​Ensuring digital engagement between healthcare companies and their consumers aligns with regulatory requirements
  • Library
  • Engage with Confidence Managing Online Adverse Event Reporting
To download files, please accept Functional Cookies. These cookies provide enhanced functionality for a better user experience.

The healthcare industry, and, specifically, consumer health companies, are waking up to the enormous potential offered by social media and other online data sources to make better informed decisions around brand, product development and commercialization, but these opportunities don’t come without a degree of risk.

FINDING THE HEALTHCARE INDUSTRY’S NEEDLE IN THE ELECTRONIC HAYSTACK

The mention of adverse events through online chatting by consumers on social media could be causing healthcare executives to have sleepless nights. However, the phenomenon actually pre-dates the Facebook generation by some time.

“Adverse events have been reported by people on the internet ever since there were chat rooms or an ability to post online,” says Joy Liu, a partner at law firm Ropes & Gray, suggesting the issue first reared its head in the early 1990s.

So how big is this problem for the consumer health industry? Initially, the regulatory risk from direct twoway online dialogue was clear. “There was recognition that if consumer health companies let people leave comments on one of their pages, the company, having viewed these comments, would therefore be obliged to respond and take action,” elaborates Liu, resulting in early online consumer healthcare-related activities being mostly didactic one-way communication.

As the digital space has evolved, healthcare gradually ventured further into online dialogue, with forums and Facebook pages offering an opportunity to build connectivity with healthcare professionals and consumers. In 2011, however, companies could no longer “turn off” comments in their Facebook pages, leading companies to withdraw from the channel completely. Slowly and uncertainly they have returned, but it is to an environment where the reporting of online adverse effects is not straightforward. The challenges in managing adverse events tracking within social media remain, despite guidance published in 2014 by:

  • The FDA on “Fulfilling regulatory requirements for post-marketing submissions of interactive promotional media”
  • The AESGP to “promote self-regulatory mechanisms to ensure appropriate and effective monitoring and implementation”

Recognizing that the industry faces a number of difficulties around taking a responsible and compliant approach towards tracking online adverse events, Siva Nadarajah, General Manager, Nexxus Social at IQVIA, started working to identify solutions to two main challenges.

Firstly, the high volume of comments from online channels potentially makes screening and tracking of adverse events difficult.

Secondly, adverse events from such unstructured data sources are not always obvious, with Nadarajah highlighting that “identifying these adverse events and a lack of clarity on those cases where you cannot identify the consumer” can cause problems.

It is something the regulators are grappling with, too. Whilst the easy answer might be to simply apply existing adverse event reporting guidelines to online activities, in practice this is ambiguous.

For example, guidelines from the U.S regulators state that four criteria must be met for a reportable adverse event:

  1. An identifiable consumer
  2. An identifiable reporter
  3. A suspect product
  4. An adverse experience or fatal outcome suspected to be due to the product consumed

In reality, only some of these criteria may be met with online comments. For example, an anonymous forum poster would not fulfil criteria (1) or (2), even with a clearly reported side effect and product. Some companies take a proactive stance and actively seek the missing information but data protection can be an issue here. “If a consumer has purposefully commented from a closed profile we have to be careful not to infringe privacy,” says Nadarajah. As a result, Liu notes that healthcare companies prefer to manage these issues offline and “would much rather have someone call the hotline so that the person answering the phone can ask them all the relevant questions.”

After years of waiting for the FDA to provide some clarity on the subject, the recent draft guidance is helpful in that it says that companies are only responsible for the content that they produce or sponsor on behalf of their brands. However, this doesn’t resolve the issue of how to run effective and compliant post-marketing surveillance activities on the online content they are responsible for.


DOWNLOAD TO LEARN MORE

Related solutions

You may also be interested in

Video
IQVIA Vigilance Intake
Case Study
Preventing Early Drug Discontinuation
Institute Report
2025 Indicators of Progress for the Life Sciences Sector
Prev
Next
Contact Us